If you’re still hand-wringing over whether VWCE, VUSA, or CSPX deserves your 2026 EUR portfolio, you’re already behind the curve. The right ETF isn’t just a matter of taste—it’s about cold, hard numbers, tax efficiency, and actually capturing the global market upside that too many Europeans leave on the table.
Let’s be clear: most so-called “global” ETF portfolios in Europe are either stealth bets on the US, or they’re riddled with hidden costs and tax inefficiencies. If you want to put your money where the growth actually is, you need to cut through the marketing and look at VWCE vs VUSA vs CSPX with ruthless objectivity. Here’s how they stack up—no excuses, no equivocation.
VWCE vs. VUSA vs. CSPX: The Index Coverage That Actually Matters
Here’s the honest truth: index coverage is the single biggest driver of your long-term EUR returns. VWCE tracks the FTSE All-World, giving you over 3,700 stocks across developed and emerging markets. CSPX (tracking the S&P 500) and VUSA (another S&P 500 tracker) limit you to the top 500 US mega-caps.
Let’s run the numbers: In the 10 years to January 2026, S&P 500 UCITS ETFs (like CSPX and VUSA) have returned an eye-watering 212% in EUR terms. VWCE’s All-World exposure returned 154% over the same period. Source: Vanguard, iShares, Xtrackers.
But here’s what the ETF sales pitch won’t tell you: US outperformance is not a law of nature. S&P 500’s decade-long rally was powered by a handful of US tech behemoths (think Apple, Microsoft, Nvidia). As European growth ETFs see inflows while US mega caps cool, diversification looks a lot less optional going into 2026.
Bottom line: if you think the future will look nothing like the past, VWCE’s global reach is your hedge. If you’re all-in on American exceptionalism, CSPX or VUSA is the high-octane bet.
Total Return, EUR Costs, and Efficiency: The Facts
Let’s strip away the marketing. VUSA and CSPX are S&P 500 trackers—but CSPX wins on cost and tax treatment. VWCE is the broad diversified play, but it’s not free.
- VWCE: Ongoing charges (TER) of 0.22%. Dividend accumulation. Largest UCITS ETF by AUM in Europe (€30B+ as of Q1 2026).
- CSPX: TER of 0.07%. Accumulating dividends. Irish domicile—zero US withholding tax on dividends. Over €50B AUM. Often tighter spreads than VUSA.
- VUSA: TER of 0.07%. Distributes dividends. UK domicile—exposed to unrecoverable US withholding tax (15%). Lower AUM, less liquidity than CSPX.
And yes, that 0.15% tax difference between CSPX and VUSA isn’t trivial. Over a decade, on a €100,000 investment, you’re leaving over €2,000 on the table, compounding away in Dublin for Irish-domiciled CSPX holders.
Key point: CSPX is the most cost- and tax-efficient S&P 500 ETF for Europeans. VWCE is pricier, but you’re buying insurance against US stagnation.
Don’t forget currency risk. All three ETFs are USD-based, but with EUR share classes, so you’re always tied to the dollar’s fate. In 2022–2023, EUR investors gained a kicker just from the dollar’s surge. In 2026, with a potentially weakening USD, the effect could reverse. Don’t pretend you’re not exposed.
The Bottom Line
If you want pure, cheap S&P 500 exposure, buy CSPX. Want “set and forget” world coverage? VWCE. VUSA is the tax-inefficient compromise—don’t bother.
Which ETF Fits Which Portfolio in 2026?
Here’s when each fund genuinely makes sense:
- VWCE: Perfect for hands-off, one-fund investors who want global equity exposure. Ideal for long-term EUR-based savers, FIRE aspirants, and those worried about “US everything” risk. Not the cheapest, but the peace of mind is worth the 0.22% TER.
- CSPX: For those convinced the US will continue to dominate, or for tactical investors who want to overweight US large caps. If you’re using a core-satellite approach, CSPX is the best-in-class S&P 500 building block. Also a favorite in ETF portfolio construction for Europeans.
- VUSA: Only makes sense if your broker can’t access CSPX, or you really crave quarterly cash dividends. Otherwise, you’re just handing money to the tax man.
And don’t forget: the real pros benchmark their ETF portfolios properly. Most retail investors still get this wrong (here’s how to fix that).
To Be Fair: The Case Against VWCE and CSPX
It’s only fair to acknowledge the cracks in the narrative. VWCE’s emerging market allocation (about 12%) has been dead weight for a decade. China’s meltdown, Latin America’s volatility—it’s dragged on returns compared to the all-US S&P 500 crews. If globalisation frays further, emerging market exposure could stay a liability.
CSPX and VUSA? If the US suffers a lost decade (remember Japan in the 1990s?), you’ll regret betting the farm on American stocks. Plus, S&P 500 is as concentrated as ever: as of January 2026, the top 7 stocks make up 28% of the whole index. That’s not diversification—it’s a tech-tilted rollercoaster.
Skeptics say: “Why not just split your bet? 70% CSPX, 30% VWCE.” That’s called indecision, not strategy. Pick a lane and own it.
And yes, for those obsessed with the very last basis point, you’ll find even lower TERs on obscure synthetic ETFs. But good luck handling counterparty risk, regulatory headaches, and illiquidity. There’s a reason why most serious European ETF investors stick to the “big three.” For deeper context, see The Complete Guide to Building Wealth with European ETFs (2026 Edition).
The Verdict: 2026 Belongs to CSPX and VWCE—But Only If You Know Your Bet
There’s no room for fence-sitting in 2026. If you want the lowest fees, best tax setup, and pure S&P 500 exposure, CSPX is your alpha dog. If you want to sleep at night knowing you own the entire world—warts, wars, and all—VWCE is your ticket. VUSA is a relic; don’t let inertia rob your returns.
By 2028, I expect Europe’s ETF AUM will be split 70/30 between world funds (like VWCE) and efficient US trackers (CSPX). The losers? Those clinging to high-fee, tax-inefficient ETF relics.
My call: make your choice now, allocate with conviction, and stop tinkering. Otherwise, you’ll still be reading ETF comparison articles in 2027, while everyone else is counting their gains.
Disclaimer: This article reflects the author's opinion and is for educational purposes only. It does not constitute financial advice. Always do your own research before making investment decisions.